AI assistant
OCULAR THERAPEUTIX, INC — Director's Dealing 2014
Jul 25, 2014
31615_dirs_2014-07-24_0c8c0378-6cd2-4ef4-8640-5748019f0f77.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: OCULAR THERAPEUTIX, INC (OCUL)
CIK: 0001393434
Period of Report: 2014-07-24
Reporting Person: Ankerud Eric (EVP, Clinical, Reg. & Quality)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 77651 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $1.22 | 2021-08-11 | Common Stock (18939) | Direct | |
| Stock Option (right to buy) | $2.49 | 2023-01-30 | Common Stock (9469) | Direct | |
| Stock Option (right to buy) | $8.80 | 2024-03-30 | Common Stock (18939) | Direct |
Footnotes
F1: This option was granted on August 12, 2011 and vests over four years, with 25% of the shares underlying the option vesting on August 12, 2012 and 2.0833% of the shares vesting monthly thereafter.
F2: This option was granted on January 31, 2013 and vests over four years, with 25% of the shares underlying the option vesting on February 1, 2014 and 2.0833% of the shares vesting monthly thereafter.
F3: This option was granted on March 31, 2014 and vests over four years, with 25% of the shares underlying the option vesting on March 31, 2015 and 2.0833% of the shares vesting monthly thereafter.